← Back to directory
FC
F-Prime Capital
Cambridge, MA, USAWebsite ↗
F-Prime Capital is a global venture capital firm that emerged from Fidelity Investments' venture capital division, with a legacy of over 50 years. It operates as an independent subsidiary of Fidelity, investing in healthcare and technology companies to foster world-changing breakthroughs.
Last raised
Unknown
Latest fund size
—
F-Prime Capital Partners Life Sciences Fund VIII
AUM
$5.3B
estimated
Funds raised
Capital this firm has raised, newest first
F-Prime Capital Partners Life Sciences Fund VIII
Unknown
—
F-Prime Capital Partners Life Sciences Fund VII
Unknown
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| BoolSi | — | — | Jun 2026 | |
| Immuneel | — | — | Jan 2026 | |
| Fazeshift | — | — | Jan 2026 | |
| Tenpoint Therapeutics | Series B | — | Jan 2026 | |
| AlfredLead | Series A | — | Jan 2026 | |
| Unbox Robotics | Series B | — | Jan 2026 | |
| Nocion Therapeutics | Series B | — | Jan 2026 | |
| Paradigm | Series B | — | Dec 2025 |
Sources
Where this data came from